Hot Warren Buffett Companies To Buy Right Now

Familiarity can serve as a great starting point when searching for stocks. Products we use on a daily basis -- like now during the dog days of summer -- can provide inspiration for identifying possible investment opportunities. In fact, investing greats Peter Lynch and Warren Buffett have made tons of money in the market by buying what they know.

Let's look at three summertime stocks that are worth a closer look.

Lowe's (NYSE: LOW  )

Source: Wikimedia Commons.

We all want to spruce up our lawns, get that new barbecue grill, and have the pool looking good. For any home and garden need you might have this summer, Lowe's is there to help. Without a doubt, Lowe's is enjoying a housing recovery tailwind. But Lowe's pending acquisition of Orchard Supply Hardware (NASDAQ: OSH  ) may unlock even more value for shareholders. Lowe's anticipates operating the West Coast chain as a standalone business and might offer Sears b (NASDAQ: SHLD  ) rands, such as Craftsman and Kenmore, at Orchard Supply stores (as OSH stores currently do).

Hot Warren Buffett Companies To Buy Right Now: Nuveen Insured New York Select Tax-Free Income Portfolio(NXN)

Nuveen New York Select Tax-Free Income Portfolio is a closed-ended fixed income mutual fund launched by Nuveen Investments Inc. It is managed by Nuveen Asset Management. The fund invests in the fixed income markets of United States. It invests in the securities of companies that operate across diversified sectors. The fund primarily invests in municipal bonds with an average credit quality of Baa/BBB or better. It employs fundamental analysis to create its portfolio. The fund benchmarks the performance of its portfolio against Barclays Capital New York Municipal Bond Index and S&P New York Municipal Bond Index. Nuveen New York Select Tax-Free Income Portfolio was formed on June 19, 1992 and is domiciled in the United States.

Hot Warren Buffett Companies To Buy Right Now: Shire plc (SHPGY)

Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products. It operates in two segments, Specialty Pharmaceuticals and Human Genetic Therapies. The Specialty Pharmaceuticals segment offers products for the treatment of attention deficit and hyperactivity disorder, including VYVANSE, a pro-drug stimulant; INTUNIV, an alpha-2A receptor; EQUASYM; and ADDERALL XR. It also produces PENTASA and LIALDA/MEZAVANT for the treatment of active ulcerative colitis; and RESOLOR, which is 5-HT4 receptor agonist that stimulates gastrointestinal motility. In addition, this segment provides FOSRENOL for use in end-stage renal failure patients receiving dialysis; CALCICHEW, a range of calcium and calcium/vitamin D3 supplements; CARBATROL, an anti-convulsant for individuals with epilepsy; REMINYL/REMINYL XL for the symptomatic treatment of dementia of the Alzheimer type; and XAGRID for the reduction of elevated platelet counts, as well as for the treatment of thrombocythemia. The Human Genetic Therapies segment offers REPLAGAL for Fabry disease; ELAPRASE for the treatment of hunter syndrome; FIRAZYR for hereditary angioedema; and VPRIV for the treatment of type 1 Gaucher disease. The company also licenses its patented antiviral products for human immunodeficiency virus and Hepatitis B. In addition, it is developing various products in the areas of attention deficit hyperactivity disorder, human genetic therapies, and gastrointestinal diseases, as well as in other therapeutic areas. The company markets its products through distributors in North America, the Republic of Ireland, the United Kingdom, and internationally. It has collaboration agreements with Santaris Pharma A/S, Renovo Limited, and Acceleron Pharma, Inc. Shire plc was founded in 1986 and is based in Dublin, Ireland.

Hot Biotech Stocks To Own Right Now: Lon & Assoc Props(LAS.L)

London & Associated Properties PLC, along with its subsidiaries, engages in the property investment and development in the United Kingdom. It holds a portfolio of retail properties, including Antiquarius and Chenil House in Chelsea; King Edward Court, a shopping centre in Windsor; Kings square in west Bromwich; Market Row and Brixton Village in London; Orchard Square shopping centre in Sheffield; Saxon Square, a medium sized building with residential upper parts to the rear of shopping centre; and the Mall and adjacent buildings in Islington. The company is based in London, the United Kingdom.

Hot Warren Buffett Companies To Buy Right Now: Under Armour Inc.(UA)

Under Armour, Inc. develops, markets, and distributes performance apparel, footwear, and accessories for men, women, and youth primarily in the United States, Canada, and internationally. It offers products made from moisture-wicking synthetic fabrics designed to regulate body temperature and enhance performance regardless of weather conditions. The company provides its products in three fit types: compression (tight fitting), fitted (athletic cut), and loose (relaxed) extending across the sporting goods, outdoor, and active lifestyle markets. Its footwear offerings comprise football, baseball, lacrosse, softball, and soccer cleats; slides; performance training footwear; and running footwear. The company also provides baseball batting, football, golf, and running gloves, as well as licenses bags, socks, headwear, custom-molded mouth guards, and eyewear that are designed to be used and worn before, during, and after competition. Under Armour sells its products through retai l stores, as well as directly to consumers through its own retail outlets and specialty stores, Website, and catalogs. The company was founded in 1996 and is headquartered in Baltimore, Maryland.

Advisors' Opinion:

• [By Glenn]  

  Current Price: $27.27 12-month target: $37

  I see potential in opportunities for new product adjacencies, and expanding distribution worldwide. Footwear growth will continue to increase. Revenues for these products have increased over 69% in 2009. Adding to this I still see growth in Under Armour’s apparel sales, which are up 8%. Under Armor had yet to even break into the international market, which offers a plethora of new opportunities for this growing brand. I believe sales will rise drastically in 2010 driven by international sales, new women’s clothing line, and expansion within their own footwear line.
• [By Victor Mora]

  Under Armour provides athletic apparel, footwear, and accessories to a growing health and wellness, athletic, and fitness enthusiast population around the world. The stock has been on a powerful move towards higher prices that has led to it trading at all-time highs. Earnings and revenue figures have increased over most of the last four quarters which has led to excited investors. Relative to its peers and sector, Under Armour has led in year-to-date performance by a wide margin. Look for Under Armour to OUTPERFORM.